Published July 25, 2015 | Version v1
Journal article

GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells

  • 1. Cancer Science Institute of Singapore, National University of Singapore, Singapore (Singapore)
  • 2. Department of Haematology-Oncology, National University Hospital of Singapore, Singapore (Singapore)

Description

Platinum based therapy is commonly used in the treatment of advanced gastric cancer. However, resistance to chemotherapy is a major challenge that causes marked variation in individual response rate and survival rate. In this study, we aimed to identify the expression of GTSE1 and its correlation with cisplatin resistance in gastric cancer cells. Methylation profiling was carried out in tissue samples from gastric cancer patients before undergoing neoadjuvent therapy using docetaxel, cisplatin and 5FU (DCX) and in gastric cancer cell lines. The correlation between GTSE1 expression and methylation in gastric cancer cells was determined by RT-PCR and MSP respectively. GTSE1 expression was knocked-down using shRNA's and its effects on cisplatin cytotoxicity and cell survival were detected by MTS, proliferation and clonogenic survival assays. Additionally, the effect of GTSE1 knock down in drug induced apoptosis was determined by western blotting and apoptosis assays. GTSE1 exhibited a differential methylation index in gastric cancer patients and in cell lines that correlated with DCX treatment response and cisplatin sensitivity, respectively. In-vitro, GTSE1 expression showed a direct correlation with hypomethylation. Interestingly, Cisplatin treatment induced a dose dependent up regulation as well as nuclear translocation of GTSE1 expression in gastric cancer cells. Knock down of GTSE1 enhanced cisplatin cytotoxity and led to a significant reduction in cell proliferation and clonogenic survival. Also, loss of GTSE1 expression caused a significant increase in P53 mediated apoptosis in cisplatin treated cells. Our study identifies GTSE1 as a biomarker for cisplatin resistance in gastric cancer cells. This study also suggests the repressive role of GTSE1 in cisplatin induced apoptosis and signifies its potential utility as a therapeutic target for better clinical management of gastric cancer patients. The online version of this article (doi:10.1186/s12885-015-1550-0) contains supplementary material, which is available to authorized users

Availability note (English)

Available from http://dx.doi.org/10.1186/s12885-015-1550-0; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514980

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
15
Journal Page Range
vp.
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
47084163
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHEMOTHERAPY; CORRELATIONS; IN VITRO; METHYLATION; NEOPLASMS; PATIENTS; RADIATION DOSES
Descriptors DEC
CHEMICAL REACTIONS; DISEASES; DOSES; MEDICINE; THERAPY

Optional Information

Copyright
Copyright (c) Subhash et al. 2015
Notes
PMCID: PMC4514980; PMID: 26209226; PUBLISHER-ID: 1550; OAI: oai:pubmedcentral.nih.gov:4514980